Glenmark Pharmaceuticals allots 172494 Equity Shares pursuant to Conversion of FCCBs

Glenmark Pharmaceuticals Ltd has announced that the Board of Directors of the Company at its meeting held on January 21, 2008, inter alia, has approved conversion of Zero Coupon Foreign Currency Convertible Bonds (FCCBs) amounting to US$ 1,000,000 into 172,494 Equity Shares at a price of Rs 253.11 per share of face value Rs 1 each out of US$ 50,000,000 Zero Coupon Foreign Currency Convertible Bonds issued in 2005.

Source : Equity Bulls

Keywords